LMR Partners LLP

Position in ELAN — Elanco Animal Health Inc

CIK 1578621 LONDON, X0

Position in ELAN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$27,887,016

+$22,972,785 QoQ

Shares Held

1,165,358

+248.4% QoQ

Ownership

0.233%

of shares outstanding

% of Portfolio

0.43%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

LMR Partners LLP holds $45,048,985 across 4 Drug Manufacturers - Specialty & Generic names. ELAN ranks #1 (61.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ELAN	Elanco Animal Health Inc This page	1,165,358	$27,887,016
2	UTHR	UNITED THERAPEUTICS Corp	16,436	$9,746,219
3	NBIX	Neurocrine Biosciences Inc	55,545	$7,317,497
4	ESPR	Esperion Therapeutics, Inc.	35,859	$98,253

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$27,887,016	1,165,358	+248.4%	Shares	Sole	2026-05-15
2024-09-30	$4,914,231	334,529	-49.5%	Shares	Sole	2024-11-07
2024-06-30	$9,557,479	662,334	+67.6%	Shares	Other	2024-08-14
2024-03-31	$6,434,735	395,254	-2.9%	Shares	Sole	2024-05-15
2023-12-31	$6,066,818	407,169	+854.0%	Shares	Sole	2024-02-14
2023-06-30	$429,340	42,678	-73.7%	Shares	Sole	2023-08-14
2020-12-31	$4,983,875	162,500	-60.6%	Shares	Sole	2021-02-16
2020-06-30	$8,854,388	412,792	+8.8%	Shares	Sole	2020-08-14
2020-03-31	$8,492,504	379,299	—	Shares	Sole	2020-08-14
No filing history on record for this holder in this stock.